MMED highlights diabetes technology growth and expanding global reach
MMED says a comprehensive diabetes technology platform is driving strong growth, citing a refreshed product portfolio, best-in-class clinical outcomes, accelerating revenue, margin expansion, and a solid balance sheet.
A comprehensive diabetes technology platform is driving strong growth, with a refreshed product portfolio, best-in-class clinical outcomes, and expanding global reach.
Financial performance is robust, with accelerating revenue, margin expansion, and a solid balance sheet supporting continued innova…